SCHEMBL21636241

SCHEMBL21636241

Cc1nn(-c2ccccc2)c2c1CCc1sccc1-2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.43
▸ SHMT2 P34897 1/20 0.40
▸ USP7 Q93009 1/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3R2 O00459 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ PIK3R5 Q8WYR1 1/20 0.40
▸ PIK3R3 Q92569 1/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ ADRA2A P08913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21636250 0.84 F10 (0.34) SHMT2CCNA2CDK2CCNA1
SCHEMBL21625157 0.76 SHMT2 (0.59) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625120 0.74 SHMT2 (0.43) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21636256 0.74 SHMT2 (0.56) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625205 0.73 SHMT2 (0.42) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625204 0.73 ALDH1A1 (0.56) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625070 0.73 PIK3CD (0.55) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625073 0.72 SHMT2 (0.48) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625114 0.72 CDK2 (0.43) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625122 0.71 PIK3CD (0.53) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO disclosed
Send feedback